And you Really Think God will Bless us? LGBT Flags Flown at U.S. Embassies
PAYBACK: Dr. Judy Mikovits Comes Out Swinging; Drops NEW Bombs on Dr. Fauci & CDC

Why Does Fauci Hold Patents on a Key HIV Component Used to Create COVID-19

image from corsination.comFrom Sept 2020 Plain Truth

Why does Dr. Anthony Fauci’s name appear on 4 U.S. patents for a key glycoprotein that appears to have been inserted into a SARS virus chassis to create the current COVID-19 epidemic?

The legal portal Justia.com lists the following “patents by inventor Anthony S. Fauci” involving a glycoprotein found in the HIV-1, a disease that attacks the human immune system, leading to the Acquired Immune Deficiency Syndrome, more commonly known as AIDS.  In 1990, Fauci held the same position at the NIH that he holds today. Fauci made his mark around the anti-viral medications that were developed by Big Pharma to combat the AIDS epidemic raging at that time.

This same glycoprotein, identified as Glycoprotein 120, or simply as GP120, has also been found to be a key component of the current COVID-19, a disease that appears to combine a HIV-1 attack on the human immune system, with SARS CoV-1, the pathogen from the original SARS (“Severe Acute Respiratory System”) that created an international pandemic in 2002-2003.  The pathogen in COVID-19 is named SARS CoV-2 in medical scientific literature.

The four patents on which Fauci is named as an inventor are the following:

  • Patent Number: 9896509, patent granted August 3, 2016. “Use of antagonists of the interaction between HIV120 and ?4?7 integrin.
  • Publication Number: 20160333309, patent application filed August 3, 2016. “Use of Antagonists of the Interaction Between HIV GP120 and A4B7 Integrin.
  • Patent Number: 9441041, patent granted September 13, 2016. “Use of antagonists between HIV GP120 and ?4?7 integrin.”
  • Publication Number 2016007586, patent application filed September 21, 2015. “Use of antagonists of the Interaction Between HIV GP120 and A4B7 Integrin.”

CLICK HERE FOR MORE

Comments